Acasti Pharma Inc. (ACST) |
| 3.37 0.13 (4.01%) 10-25 16:00 |
| Open: | 3.4268 |
| High: | 3.448 |
| Low: | 3.2 |
| Volume: | 27,682 |
| Market Cap: | 34(M) |
| PE Ratio: | -2.36 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 3.6 |
| 52w Low: | 1.98 |
Acasti Pharma Inc. operates as a biopharmaceutical firm, concentrating its efforts on developing and marketing pharmaceutical solutions specifically for cardiovascular conditions. The company is currently exploring potential strategic alliances to further the clinical development of its drug candidate, CaPre. This Canadian company, which was established in 2002, has its main offices located in Laval.
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Sat, 30 May 2026
GRCE - Grace Therapeutics Inc Stock Price and Quote - Finviz
Thu, 24 Apr 2025
Acasti Pharma (ACST) Stock Price, News & Analysis - stocktitan.net
Wed, 04 Dec 2024
Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference - The Manila Times
Wed, 20 Nov 2024
Acasti Pharma Inc (NASDAQ: ACST) Share Price, ACST Stock News, ACST Share Price & Updates - kalkine.ca
Fri, 25 Oct 2024
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. - Yahoo Finance
Wed, 25 Jul 2018
Acasti Pharma (ACST-Q) Stock Price and News - theglobeandmail.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
